ProSomnus, Inc. Common Stock
NASDAQ:OSA
0.47 (USD) • At close September 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7.458 | 7.838 | 7.071 | 6.934 | 5.808 | 5.792 | 4.998 | 4.86 | 3.743 | 4.403 | 3.703 | 3.438 | 2.985 |
| Cost of Revenue
| 3.833 | 4.134 | 3.58 | 3.171 | 2.757 | 2.687 | 2.54 | 2.322 | 1.578 | 2.138 | 1.759 | 1.746 | 1.434 |
| Gross Profit
| 3.625 | 3.705 | 3.491 | 3.763 | 3.052 | 3.105 | 2.458 | 2.538 | 2.165 | 2.265 | 1.944 | 1.692 | 1.551 |
| Gross Profit Ratio
| 0.486 | 0.473 | 0.494 | 0.543 | 0.525 | 0.536 | 0.492 | 0.522 | 0.578 | 0.514 | 0.525 | 0.492 | 0.52 |
| Reseach & Development Expenses
| 0.955 | 1.367 | 1.04 | 1.376 | 1.019 | 1.066 | 0.689 | 0.669 | 0.558 | 0.46 | 0.57 | 0.47 | 0.43 |
| General & Administrative Expenses
| 2.485 | 3.97 | 3.427 | 4.48 | 3.353 | 5.681 | 1.577 | 1.288 | 1.354 | 1.233 | 1.129 | 1.053 | 1.049 |
| Selling & Marketing Expenses
| 1.976 | 3.378 | 3.241 | 3.643 | 2.824 | 2.415 | 2.319 | 2.013 | 2.117 | 1.668 | 1.508 | 1.444 | 1.3 |
| SG&A
| 4.461 | 7.348 | 6.667 | 8.123 | 6.177 | 8.097 | 3.896 | 3.302 | 3.471 | 2.901 | 2.637 | 2.497 | 2.349 |
| Other Expenses
| 0 | 2.653 | -0.264 | -0.123 | -0.407 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 5.416 | 8.715 | 7.707 | 9.499 | 7.196 | 9.162 | 4.585 | 3.971 | 4.029 | 3.361 | 3.207 | 2.967 | 2.162 |
| Operating Income
| -1.791 | -5.01 | -4.216 | -5.736 | -4.144 | -2.127 | -2.553 | -1.626 | -1.864 | -1.104 | -1.264 | 0.003 | -1.228 |
| Operating Income Ratio
| -0.24 | -0.639 | -0.596 | -0.827 | -0.713 | -0.367 | -0.511 | -0.334 | -0.498 | -0.251 | -0.341 | 0.001 | -0.411 |
| Total Other Income Expenses Net
| 5.232 | -1.859 | -5.533 | 7.881 | -2.748 | 4.329 | -0.996 | -1.197 | -1.117 | -0.147 | 1.003 | 1.278 | -0.105 |
| Income Before Tax
| 3.441 | -6.869 | -11.239 | 0.905 | -6.892 | 2.202 | -3.549 | -2.823 | -2.981 | -2.182 | -1.121 | -0.777 | -1.333 |
| Income Before Tax Ratio
| 0.461 | -0.876 | -1.589 | 0.131 | -1.187 | 0.38 | -0.71 | -0.581 | -0.796 | -0.496 | -0.303 | -0.226 | -0.447 |
| Income Tax Expense
| 0 | 0 | 1.489 | 1.24 | 1.576 | -6.74 | -0.426 | 0.001 | 0.021 | 0.008 | -1.003 | 0.004 | 0.004 |
| Net Income
| 3.441 | -6.869 | -11.239 | 0.905 | -8.468 | 8.942 | -3.123 | -2.824 | -3.001 | -2.182 | -1.121 | -0.781 | -1.337 |
| Net Income Ratio
| 0.461 | -0.876 | -1.589 | 0.131 | -1.458 | 1.544 | -0.625 | -0.581 | -0.802 | -0.496 | -0.303 | -0.227 | -0.448 |
| EPS
| 0.2 | -0.42 | -0.7 | 0.056 | -0.53 | 0.56 | -0.19 | -0.18 | -0.19 | -0.14 | -0.07 | -0.049 | -0.055 |
| EPS Diluted
| -0.02 | -0.42 | -0.7 | -0.014 | -0.53 | 0.56 | -0.19 | -0.18 | -0.19 | -0.14 | -0.07 | -0.049 | -0.055 |
| EBITDA
| -1.791 | -4.335 | -4.48 | -5.859 | -4.551 | -6.057 | -2.127 | -1.433 | -1.627 | -0.909 | -1.017 | -1.275 | -1.031 |
| EBITDA Ratio
| -0.24 | -0.553 | -0.634 | -0.845 | -0.783 | -1.046 | -0.426 | -0.295 | -0.435 | -0.207 | -0.275 | -0.371 | -0.345 |